Motilal Oswal's research report on Colgate
CLGT reported better-than-expected operating performance, driven by early signs of recovery in rural markets. It reported double-digit sale growth (up 10.6% YoY). GP margin exceeded expectations, reaching 68.4% (est. 66.8%), driven by the growth of the oral care category. Furthermore, a decrease in staff costs and other expenses led to 440bpYoY improvement in EBITDA margin. The company will continue to focus on innovation, productivity, and premiumization to revive growth. With a cautious near-term outlook on demand, we reiterate our Neutral rating on the stock.
Outlook
The valuation will arrive at a TP of INR1,830 (target multiple of 38x FY25E EPS, close to five-year average). Therefore, we reiterate our Neutral rating on the stock.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.